“Speaking of Amway, what are YOUR thoughts on…?”

Buried at the end of the last post — on the GQ magazine story related to Personalized Health — was a jewel of a link to a quick, four-minute streaming video from the Interleukin Genetics site. It’s simply titled, The Science Behind Interleukin Genetics. 

If you’ve ever pondered over how to explain to a retail customer (or a potential business associate) what the Gensona DNA tests are about and the life-long value of the information they provide, now you don’t (have to ponder). Just refer your retail customer or potential business associate to this link for a quick, easy-to-understand presentation.

The Science Behind Interleukin Genetics

****************

Still with me? Attention span longer than you  thought? (hehe) 

Beyond that, you should still know something about the Nutrilite brand and why it gives us such a unique position in the marketplace. If you don’t know how to talk about Nutrilite’s history and the just-in-time fresh fresh freshness of the organic functional-whole-food-based products you represent, here are a few more “movies” to which you can go (and take your retail customer along).

Washington State organic farm

Mexico organic farm

Brazil organic farm

Optimal Health: The Heart of the Original Brand

Lifestyle

Personalization

Nutrigenomics

Nutrilite clinical validation studies

Nutrilite research associations

SPEAKING OF AMWAY, don’t foget to watch this space for a timely and provocative three-part series coming very soon from the pen keyboard of Chuck Lia.

Blessings for a great day…

written by rdknyvr \\ tags: Alticor, Amway, Amway Global, DNA tests, Gensona, GQ magazine, Interleukin Genetics, nutrigenomics, Nutrilite, optimal health, Personalized Health

NOTE TO READERS: text below in bold and blue is hotlinked to additional background info.  

This new article in GQ Magazine, The Book of Me, is of keen interest in that it demonstrates how personal genomics and Personalized Health are now growing in mass market interest in general media outlets, and not just science-oriented journalism and publications.Someone in the Alticor organization had the exceptional foresight back around 2002 or 2003 to recommend an ‘angel investment’ in Interleukin Genetics, which had made some key discoveries — pre-Human Genome Project completion — which are turning out to be core to understanding how our personal genetics influences the ageing process and chronic health conditions related thereto. Interleukin was able to apply for a number of patents based on their unique discoveries and thus claim some significant IP real estate in the “land rush” around human genome research which is shaping the future of health and health care. Alticor has thus far shown good patience with their investment in Interleukin and has provided its Distributors with an unparalleled product and business development opportunity with the Gensona DNA tests, and Nutrilite’s IL-1 Heart Health supplement — the world’s first clinically validated (published in peer-reviewed and respected scientific journals) nutrigenomic supplement – with more in the Nutrilite and Interleukin research pipelines. The article in GQ is an easy read and well-written, almost in a mystery novel genre by a top-selling novelist, so your time spent reading will be enjoyable for those who don’t think they “like” science related stuff, and a joy for those of us who see the future now and can’t wait.A key quote from the article — key for me, at least: 

He [George Church, Harvard University] defends the coming revolution, comparing it to the birth of personal computing in the late 1970s. That earlier revolution was all about mass empowerment, going, he says, “from a few people in the priesthood that guarded the mainframes, to everybody.” But few people saw the potential of that revolution early on: “Just like with personal computing, until there are some compelling stories involving real products [my emphasis] the only people who are going to get what’s happening are the ones who can imagine things that aren’t yet there.”                                        

 SPEAKING OF AMWAY GLOBAL, where do you rank Personalized Health and Nutrilite Health in your list of business development priorities? Is it “hot” or is it “not” for you, and why? Second, what is Amway Global doing well to assist you in understanding and marketing the Gensona DNA tests and the Nutrilite IL-1 Heart Health, and what in your view might they do better?  Before you answer that last question, watch this video clip. 

written by rdknyvr \\ tags: Alticor, Amway, Amway Global, DNA tests, genomics, Gensona, George Church, GQ, GQ magazine, Harvard, Human Genome Project, IL-1 Heart Health, Interleukin Genetics, Nutrigenomic supplements, nutrigenomics, Nutrilite, personal genomics, Personalized Health, The Book of Me, XS Gold Energy

For those of us focusing on the Personalized Health opportunity, the following excerpt from a press release this morning definitely adds a spring to our step (see quoted section below).

 With Personalized Health — which includes Interleukin Genetics’s patent protected IP and DNA tests, which we market under the Gensona brand, and the IL-1 Heart Health supplement patented by Nutrilite — we truly have an opportunity to reshape the health care debate in North America, even more so than the politicians campaigning for election at this moment in both the US and Canada.

As of next year, 2009, that same Personalized Health opportunity will be available to our colleagues in Asia as well, when Gensona DNA tests are rolled out for markets there.

Paper Reports Value of Specific Nutritional Products is Dependent on Individual’s Genetic Make-up WALTHAM, Mass., Sept. 12

WALTHAM, Mass., Sept. 12 /PRNewswire-FirstCall/ — Researchers at
Interleukin Genetics, Inc. (Amex: ILI), today received the 12th John M. Kinney Award for Nutrition and Metabolism at the annual Congress of the European Society of Parenteral and Enteral Nutrition, in Florence, Italy. The award was given for the paper, “Interleukin-1 genotype-selective inhibition of inflammatory mediators by a botanical: a nutrigenetics proof of concept,” which was published in Nutrition: The International Journal of Applied and Basic Nutritional Sciences (2007;23:844-852).

Kenneth Kornman, Ph.D., Chief Scientific Officer at Interleukin Genetics, and the first author on the publication, commented, “We are honored to receive the 12th

John M. Kinney Award for Nutrition and Metabolism. Many botanical and nutritional supplements claim to provide countless health benefits without being subjected to rigorous clinical study. Our paper reports a well- controlled clinical study has shown the value of specific nutritional products is dependent on an individual’s genetic make-up.” The study, a joint research effort by scientists at Interleukin Genetics and Nutrilite, a division of Alticor Inc., is one of the few controlled clinical trials that has shown the value of specific nutritional products is dependent on an individual’s genetic make-up. The data showed that a proprietary botanical supplement (Nutrilite IL1 Heart Health Supplement) could lower inflammation in individuals who tested positive for pro-inflammatory IL-1 gene variations from Interleukin Genetics’ Heart Health Genetic Test. These individuals also had elevated levels of C-reactive protein.

About Interleukin Genetics’ Heart Health Genetic Test

Interleukin Genetics’ Heart Health Genetic Test was developed to identify healthy individuals who are genetically predisposed to over-produce inflammation and are at an increased risk for an early first heart attack.

The Heart Health Genetic Test is marketed on a non-exclusive basis [edit: it became non-exclusive for us only as of last week] through Access Business Group International LLC, a division of Alticor Inc. Interleukin Genetics recently announced an agreement with Access Business Group International that will permit the expansion of Interleukin Genetics’ distribution network for such genetic tests.

About Nutrilite IL1 Heart Health Supplement

Nutrilite IL1 Heart Health Supplement, a proprietary botanical supplement, was developed to reduce inflammation in those individuals who are genetic over-producers. The Nutrilite IL1 Heart Health Supplement is currently marketed by Quixtar, Inc., a division of Alticor Inc.

About Interleukin Genetics

Interleukin Genetics, Inc. (Amex: ILI), is a genetics-focused personalized health company that develops preventive consumer products and genetic tests for sale to the emerging personalized health market. Focused on the future of health and medicine, Interleukin Genetics uses its leading genetics research and scientific capabilities to develop and test innovative preventive and therapeutic products. Interleukin Genetics currently offers an array of Nutraceuticals and OTCeuticals(R), which are sold at the nation’s largest food, drug and mass retailers, and has commercialized genetic tests for periodontal disease risk assessment, cardiovascular risk assessment, and general nutrition assessment.

Interleukin Genetics is headquartered in Waltham, MA. For more information about Interleukin Genetics, its products and ongoing programs, please visit
www.ilgenetics.com.

Note, of course, that as of last week, Amway Global business owners no longer have the exclusive distribution rights to the Interleukin DNA test IP. Why? Two basic reasons:

(1) Because of Quixtar’ screwed up launch and lack of support for  the Personalized Health product portfolio and health solution two-plus years ago and ongoing. They admitted as much when management acknowledged last year that Personalized Health was the victim of a “launch and abandon” product support mentality that prevailed before Steve Liebeman came on board and took control.

(2) In the old (and growth-destroying) business model — still ‘de facto’ business practice for most – based on the “Systems”-developed and promoted ”buy from yourself and teach others to do the same,” a major product/solution portfolio like Personalized Health was doomed to fail on that count as well. This could just as well be characterized as a “lack of leadership” by organizations which claim to be devoted to teaching leadership principles.

The defining advantage Independent Business Owners still have with Personalized Health is the core “value-add proposition” which we bring to the table — the ability to educate the consumer in a field which requires consumer education to be successful. Under the new retail sales focused paradigm being driven, thankfully, by Steve Lieberman and his new team, Personalized Health finally has an opportunity to flourish, and be the breakout health solution which will take Amway Global in North America way beyond the goals set by Doug DeVos and Steve Van Andel.

 I’m driving down to Portland later today to the Spotlight showcase, and hopefully Personalized Health and Amway Wellness will be getting the “showcase profile” they deserve. With Interleukin Genetics now winning these kinds of international awards for their ground-breaking research, we expect to see Personalized Health being promoted and celebrated front and center.

written by rdknyvr \\ tags: Alticor, Amway Global, Asia, C-reactive protein, DNA tests, Doug DeVos, genetics, Gensona, IL-1 Heart Health Supplement, Independent Business Owners, inflammation, Interleukin Genetics, John M. Kinney Award, Ken Kornman, nutraceuticals, nutrigenomics, Nutrilite, Nutrition, OTCeuticals, Personalized Health, Quixtar, Steve Lieberman, Steve Van Andel

According to Interleukin Genetics CEO Lew Bender on ILI’s most recent (Q1) conference call ( http://www.ilgenetics.com/ ) and an outside analyst’s report by Dutton & Associates ( http://www.centredaily.com/business/technology/story/668990.html ), we can expect a relaunch of the Gensona and Personalized Health line by Alticor sometime in Q3 (sometime in the period of July 1 to Sept. 30).

 Interestingly, the domain name AmwayWellness.com was registered by an Alticor-contracted consultant (to the best of my knowledge) as of this past Feb. 29, 2008.

And the new weight loss support market research site from Alticor, sponsored by Nutrilite, http://community.mybestsize.com/ comes with pointers to a number of interesting features, including ‘personalized health’-related gurus, and suggests a ramp-up to something exciting coming later this year.

So for those interested in building their product knowledge and expertise in nutrigenomics and optimal health, and developing a health-focused Amway-driven business, here are a few relevent resources to check out.

MP3 “Nutrigenomics, Inflammation and Obesity: A New Paradigm for Personalized Prevention” by Ruth DeBusk, RD, PhD and Colleen Fogarty Draper, MS, RD. MP3 download is $17, CD is $20 plus tax, shipping. Easy to understand for the novice. Ruth DeBusk is on the Nutrilite Science Advisory Board, and Colleen Fogarty Draper, after 6 years with Interleukin Genetics, has recently formed her own consulting/educational company in the area of nutrigenomics. At the link below, see #256 and Product Number 200730131 http://www.intelliquestmedia.com/store/search.php?a=E&c=200730

Courtesy of Colleen Fogarty Draper’s website, the following three downloadable articles provide excellent background reading.

PDF “Nutritional Genomics in Practice: Where Do We Begin?” http://www.nugenso.com/articles/DeBusk_2005.pdf

PDF “Emerging Concepts in Nutrigenomics: A Preview of What Is to Come” http://www.nugenso.com/articles/Kauwell_2005.pdf

PDF “The Genome Health Clinic and Genome Health Nutrigenomic Concepts” (this article by an Australian researcher is more technical, but will be of interest to IBOs with a health sciences background) http://www.nugenso.com/articles/Fenech_2005.pdf

BOOK “Secrets of Supplements: the Good, the Bad, the Totally Terrific” by Gloria Askew, RN and Jerre Paquette, PhD. ISBN: 978-0-9784290-0-3. Gloria is a long-time IBO and has co-authored a very readable, easy to understand book with the beginner in mind. Nowhere does she actually mention the name ‘Nutrilite’ so you can use this book to develop new customers for your Nutrilite product line. The most valuable part of the book is the list of “Ten Totally Terrific Questions” which will guide your prospective client to see that only Nutrilite meets all the key requirements. This book is worth its weight in gold to the Health Business Builder, and for what it’s worth, is being distributed by at least one System (Network 21) in North America and internationally as a key product education resource. 

Free sample chapter and Table of Contents, and online ordering at: http://www.phytemedia.com/  In Canada, Secrets of Suppements can be picked up in store or online at Chapters.

And now for the naughty question… or perhaps more accurately, a knotty question:

In your Quixtar/Amway business, what are you really selling? Are you first and foremost selling a business opportunity, or are you driving a product-based business which has the option of also being duplicated, for those interested in doing so? It’s an important question, and may differentiate between those who are “products of a System” and those who may be operating as non-affiliated “independent” IBOs (if you’ll pardon the redundancy in that).

If the question is unclear, say so and I’ll try to rephrase.

My guess is that if your business is primarily selling a business opportunity, the above resources recommendations were of relatively low relevance to you. If you are focusing on a product-driven business with a strong focus on developing long term clients – and still including networking and duplication — you will make the effort to download and read the documents above, and invest in the Ruth DeBusk MP3 and Gloria Askew’s excellent book on supplements.

SPEAKING OF AMWAY, these are just my thoughts — am I right or wrong?

written by rdknyvr \\ tags: Alticor, Amway, Amway Wellness, Colleen Fogarty Draper, duplication, Dutton & Associates, Gensona, Gloria Askew, inflammation, Interleukin Genetics, Jerre Paquette, Lew Bender, mybestsize.com, networking, nutrigenomics, Nutrilite, obesity, optimal health, Personalized Health, phytemedia.com, product-driven business, Quixtar, Ruth DeBusk, Secrets of Supplements, supplements

For those interested in staying current on happenings at IL Genetics and Gensona…  THIS WEDNESDAY, MAY 14:

Interleukin Genetics Announces Conference Call and Webcast to Discuss First Quarter 2008 Business Results

WALTHAM, MA – May 7, 2008 – Interleukin Genetics, Inc. (AMEX: ILI), announced today that it will host a conference call and webcast on Wednesday, May 14, 2008 at 4:30 p.m. ET [1:30 p.m. Pacific Time Zone] to review the Company’s first quarter 2008 financial results and provide an update on recent corporate developments.
 
To access the live call, dial 877-627-6555 (domestic) or 719-325-4869 (international). The live webcast will be available on the Investors section of the Company’s website, www.ilgenetics.com.

Replay access of the teleconference will be available for one week following the call by dialing 888-203-1112 (domestic) or 719-457-0820 (international). The passcode for the replay is 4243283. The webcast will be archived following the call at www.ilgenetics.com. 

About Interleukin Genetics
Interleukin Genetics, Inc. (AMEX: ILI) is a genetics-focused personalized health company that develops preventive consumer products and genetic tests for sale to the emerging personalized health market.

written by rdknyvr \\ tags: genetic tests, Gensona, Interleukin Genetics, nutrigenomics, Nutrilite, Personalized Health